BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 18173693)

  • 1. The use of desmopressin in open-heart surgery.
    Cattaneo M
    Haemophilia; 2008 Jan; 14 Suppl 1():40-7. PubMed ID: 18173693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of desmopressin as a hemostatic agent: a concise review.
    Franchini M
    Am J Hematol; 2007 Aug; 82(8):731-5. PubMed ID: 17492648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmopressin in inherited disorders of platelet function.
    Coppola A; Di Minno G
    Haemophilia; 2008 Jan; 14 Suppl 1():31-9. PubMed ID: 18173692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety.
    Lethagen S
    Semin Thromb Hemost; 2003 Feb; 29(1):101-6. PubMed ID: 12640572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007).
    Federici AB
    Haemophilia; 2008 Jan; 14 Suppl 1():5-14. PubMed ID: 18173689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery.
    Hackmann T; Gascoyne RD; Naiman SC; Growe GH; Burchill LD; Jamieson WR; Sheps SB; Schechter MT; Townsend GE
    N Engl J Med; 1989 Nov; 321(21):1437-43. PubMed ID: 2682243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmopressin--a haemostatic drug: state-of-the-art review.
    Lethagen S
    Eur J Anaesthesiol Suppl; 1997 Mar; 14():1-9. PubMed ID: 9088828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding.
    Svensson PJ; Bergqvist PB; Juul KV; Berntorp E
    Blood Rev; 2014 May; 28(3):95-102. PubMed ID: 24703870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin (DDAVP) in bleeding disorders of childhood.
    Sutor AH
    Semin Thromb Hemost; 1998; 24(6):555-66. PubMed ID: 10066151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
    Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction.
    Rose SS; Faiz A; Miller CH; Saidi P; Philipp CS
    Haemophilia; 2008 May; 14(3):571-8. PubMed ID: 18312366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial.
    Salzman EW; Weinstein MJ; Weintraub RM; Ware JA; Thurer RL; Robertson L; Donovan A; Gaffney T; Bertele V; Troll J
    N Engl J Med; 1986 May; 314(22):1402-6. PubMed ID: 3517650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin: a nontransfusional hemostatic agent.
    Mannucci PM
    Annu Rev Med; 1990; 41():55-64. PubMed ID: 2184748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
    van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
    Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of inherited von Willebrand disease in 2007.
    Federici AB; Mannucci PM
    Ann Med; 2007; 39(5):346-58. PubMed ID: 17701477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
    Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
    Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin in the treatment of patients with defects of platelet function.
    Cattaneo M
    Haematologica; 2002 Nov; 87(11):1122-4. PubMed ID: 12414337
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemostatic management of intraoral bleeding in patients with von Willebrand disease.
    Morimoto Y; Yoshioka A; Sugimoto M; Imai Y; Kirita T
    Oral Dis; 2005 Jul; 11(4):243-8. PubMed ID: 15984956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.